查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1939191

2026年全球主动植入式医疗设备市场报告

Active Implantable Medical Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，主动式植入式医疗设备市场规模大幅扩大，预计将从2025年的279.5亿美元成长到2026年的305.1亿美元，复合年增长率达9.1%。过去几年的成长可归因于心血管和神经系统疾病盛行率的上升、心臟起搏器和神经刺激设备的早期应用、电池技术的进步、植入生物相容性的提高以及医疗专业人员对植入式系统的日益熟悉。

预计未来几年，主动植入式医疗设备市场规模将维持强劲成长，到2030年将达到428.1亿美元，复合年增长率（CAGR）为8.8%。预测期内的成长要素包括远端患者监护解决方案的扩展、对个人化植入疗法的需求不断增长、人工智慧诊断技术的日益普及、需要长期照护的老龄人口不断增加，以及无线电力和通讯技术的进步。预测期内的关键趋势包括智慧连网植入式装置的日益普及、小型化电子元件的广泛应用、数据驱动的治疗监测的日益普及、长期植入式治疗方法的扩展，以及对设备寿命和可靠性的日益关注。

心血管疾病（CVD）盛行率的不断上升预计将推动有源植入式医疗设备市场成长。心血管疾病是指影响心臟和血管的多种疾病，与动脉粥状硬化和血栓风险增加等因素有关。有源植入式医疗设备在调节和监测某些心律不整和心臟衰竭患者的心率方面发挥着至关重要的作用。心血管疾病发生率的快速增长，特别是由于脂肪沉积的形成和血栓风险的增加，预计将推动对有源植入式医疗设备的需求。人口老化加剧也进一步促进了这项需求。例如，根据英国心臟基金会（总部位于英国的慈善机构）统计，截至2025年9月，英国有超过760万人（超过400万男性和360万女性）患有心血管疾病。受人口老化和生存率提高的推动，预计到 2030 年，这一数字将增加约 100 万，到 2040 年将增加约 200 万。因此，心血管疾病的增加正在推动主动植入式医疗设备市场的成长。

主动式植入式医疗设备市场的公司也致力于开发技术创新，例如植入式PEEK长丝，以提高客製化程度、改善病患疗效并简化生产流程。植入式PEEK长丝是专为采用积层製造技术製造医疗植入开发的专用材料。例如，总部位于英国的高性能植入式生物材料供应商Invibio于2023年3月推出了PEEK-OPTIMA AM长丝。这种长丝由植入式聚醚醚酮（PEEK）製成，PEEK以其良好的生物相容性和机械强度而闻名，使其成为植入式医疗设备的理想材料。这种新型长丝针对熔融沈积成型（FFF）进行了最佳化，旨在提高医疗领域3D列印应用的生产效率。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球主动植入式医疗设备市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 智慧、互联和嵌入式设备的整合度日益提高
    • 小型化电子元件的应用日益广泛
    • 扩大数据驱动治疗监测的应用
    • 长期植入式治疗方法的扩展
    • 更加重视设备的寿命和可靠性

第五章 终端用户产业市场分析

  • 医院
  • 专科诊所
  • 门诊手术中心
  • 心臟护理中心
  • 神经科诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球主动植入式医疗设备市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球主动植入式医疗设备市场规模、对比及成长率分析
  • 全球主动式植入式医疗设备市场表现：规模与成长，2020-2025年
  • 全球主动式植入式医疗设备市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依产品类型
  • 心臟节律器、植入式心臟整流去颤器（ICD）、神经刺激设备、人工电子耳、心室辅助装置及其他产品
  • 透过使用
  • 心血管疾病、神经系统疾病、听力障碍及其他症状
  • 最终用户
  • 医院、专科诊所及门诊手术中心
  • 按类型细分：心臟起搏器
  • 单腔心律调节器、双腔心律调节器、双心室节律器
  • 依类型细分：植入式心臟整流去颤器（ICD）
  • 经静脉植入式心律转復除颤器 (ICD)、皮下植入式心律转復除颤器 (ICD)
  • 按类型细分：神经刺激设备
  • 脊髓刺激设备、週边神经刺激设备、深部脑部刺激器
  • 依类型细分：人工电子耳
  • 单电极人工电子耳，多通道人工电子耳
  • 依类型细分：心室辅助装置
  • 左心室辅助装置（LVAD）、右心室辅助装置（RVAD）、双心室辅助装置（BiVAD）
  • 按类型细分：其他产品
  • 用于疼痛管理的神经刺激设备、植入式药物传输系统、植入式血压计

第十章 区域与国家分析

  • 全球主动式植入式医疗设备市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球主动式植入式医疗设备市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 主动植入式医疗设备市场：竞争格局及市场占有率（2024年）
  • 主动植入式医疗设备市场：公司估值矩阵
  • 主动植入式医疗设备市场：公司概况
    • Medtronic plc
    • Abbott Laboratories
    • Boston Scientific Corporation
    • BIOTRONIK SE & Co KG
    • LivaNova PLC

第37章：其他领先和创新企业

  • Cochlear Limited, MED-EL Medical Electronics, Sonova Holding AG, NeuroPace Inc, NEVRO Corp, Axonics Inc, Aleva Neurotherapeutics SA, MicroTransponder Inc, Shree Pacetronix, Berlin Heart GmbH, Jarvik Heart Inc, Blackrock Neurotech, Nurotron Biotechnology Co Ltd, CARMAT SA, Precision Neuroscience

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年主动植入式医疗设备市场：提供新机会的国家
  • 2030年主动植入式医疗设备市场：充满新机会的细分市场
  • 2030年主动植入式医疗设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MAIMD01_G26Q1

Active implantable medical devices (AIMDs) are entirely or partially embedded medical tools intended for diagnostic or therapeutic purposes, engineered to be permanently positioned within the human body.

These devices encompass a range of products including cardiac pacemakers, implantable cardioverter defibrillators (ICDs), nerve stimulators, cochlear implants, ventricular assist devices, among others. For instance, an implantable cardioverter-defibrillator (ICD) is a small, battery-powered device inserted into the chest to detect and regulate abnormal heart rhythms. They serve diverse applications such as cardiovascular, neurological treatments, aiding hearing impairment, and are employed by various end-users including hospitals, specialized clinics, and ambulatory surgical centers.

Tariffs are influencing the active implantable medical devices market by increasing costs of imported semiconductors, microelectronics, sensors, batteries, and precision manufacturing equipment. Manufacturers in North America and Europe are most affected due to complex global supply chains, while Asia-Pacific faces pricing pressure on exported implantable components. These tariffs are raising production costs and extending certification timelines. However, they are also driving localized electronics manufacturing, regional supplier partnerships, and innovation in cost-efficient implant design architectures.

The active implantable medical devices market research report is one of a series of new reports from The Business Research Company that provides active implantable medical devices market statistics, including active implantable medical devices industry global market size, regional shares, competitors with a active implantable medical devices market share, detailed active implantable medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the active implantable medical devices industry. This active implantable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The active implantable medical devices market size has grown strongly in recent years. It will grow from $27.95 billion in 2025 to $30.51 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to rising prevalence of cardiovascular and neurological disorders, early adoption of pacemakers and neurostimulators, advancements in battery technologies, improvements in implant biocompatibility, growing clinician familiarity with implantable systems.

The active implantable medical devices market size is expected to see strong growth in the next few years. It will grow to $42.81 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to expansion of remote patient monitoring solutions, rising demand for personalized implantable therapies, increasing integration of ai-enabled diagnostics, growth in aging population requiring chronic care, advancements in wireless power and communication technologies. Major trends in the forecast period include increasing integration of smart and connected implantable devices, rising adoption of miniaturized electronic components, growing use of data-driven therapeutic monitoring, expansion of long-term implantable therapies, enhanced focus on device longevity and reliability.

The active implantable medical devices market is poised for growth, driven by the increasing prevalence of cardiovascular diseases (CVD). Cardiovascular diseases encompass a range of conditions affecting the heart or blood vessels, often associated with factors such as atherosclerosis and an elevated risk of blood clots. Active implantable medical devices play a crucial role in regulating or monitoring irregular heartbeats in individuals with specific heart rhythm problems or heart failure. The surge in the incidence of cardiovascular diseases, notably due to the formation of fatty deposits and an increased risk of blood clots, is expected to propel the demand for active implantable medical devices. The rise in the geriatric population further contributes to this demand. For instance, in September 2025, according to the British Heart Foundation, a UK-based charity, over 7.6 million people in the UK-more than 4 million men and over 3.6 million women-are living with cardiovascular disease. Projections suggest that, driven by an aging population and improved survival rates, the number of individuals affected may increase by around 1 million by 2030 and by approximately 2 million by 2040. Therefore, the increase in cardiovascular diseases is driving the growth of the active implantable medical devices market.

Companies in the active implantable medical device market are also focused on developing technological advancements such as implantable PEEK filament to improve customization, enhance patient outcomes, and streamline production processes. Implantable PEEK filament is a specialized material created for making medical implants using additive manufacturing techniques. For instance, in March 2023, Invibio, a U.K.-based provider of high-performance implantable biomaterials, launched PEEK-OPTIMA AM filament. This filament is composed of implantable polyetheretherketone (PEEK) known for its biocompatibility and mechanical strength, making it ideal for implantable medical devices. The new filament is optimized for fused filament fabrication (FFF) and aims to enhance the production of medical devices, specifically designed for 3D printing applications in the medical field.

In December 2023, TekniPlex Healthcare, a U.S.-based manufacturer of medical device components, acquired Seisa Medical for an undisclosed amount. This acquisition allows TekniPlex to bolster its medical technology solutions platform, particularly in the minimally invasive and interventional therapy sectors. Seisa Medical is a U.S.-based manufacturer of active implantable medical devices.

Major companies operating in the active implantable medical devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co KG, LivaNova PLC, Cochlear Limited, MED-EL Medical Electronics, Sonova Holding AG, NeuroPace Inc, NEVRO Corp, Axonics Inc, Aleva Neurotherapeutics SA, MicroTransponder Inc, Shree Pacetronix, Berlin Heart GmbH, Jarvik Heart Inc, Blackrock Neurotech, Nurotron Biotechnology Co Ltd, CARMAT SA, Precision Neuroscience, Pins Medical, Lepu Medical Technology Co Ltd, LifeTech Scientific

North America was the largest region in the active implantable medical devices market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the active implantable medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the active implantable medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The active implanted medical devices market consists of sales of active implanted medical devices with components such as battery packs, controllers, implant kits, leads, programmers, and refill kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Active Implantable Medical Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses active implantable medical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for active implantable medical devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The active implantable medical devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Cardiac Pacemakers; Implantable Cardioverter Defibrillators (ICD); Nerve Simulators; Cochlear Implants; Ventricular Assist Devices; Other Products
  • 2) By Application: Cardiovascular; Neurological; Hearing Impairment; Other Applications
  • 3) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Cardiac Pacemakers: Single Chamber Pacemakers; Dual Chamber Pacemakers; Biventricular Pacemakers
  • 2) By Implantable Cardioverter Defibrillators (ICD): Transvenous ICDs; Subcutaneous ICDs
  • 3) By Nerve Stimulators: Spinal Cord Stimulators; Peripheral Nerve Stimulators; Deep Brain Stimulators
  • 4) By Cochlear Implants: Single-Electrode Cochlear Implants; Multichannel Cochlear Implants
  • 5) By Ventricular Assist Devices: Left Ventricular Assist Devices (LVAD); Right Ventricular Assist Devices (RVAD); Bi-Ventricular Assist Devices (BiVAD)
  • 6) By Other Products: Neurostimulators for Pain Management; Implantable Drug Delivery Systems; Implantable Blood Pressure Monitors
  • Companies Mentioned: Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; BIOTRONIK SE & Co KG; LivaNova PLC; Cochlear Limited; MED-EL Medical Electronics; Sonova Holding AG; NeuroPace Inc; NEVRO Corp; Axonics Inc; Aleva Neurotherapeutics SA; MicroTransponder Inc; Shree Pacetronix; Berlin Heart GmbH; Jarvik Heart Inc; Blackrock Neurotech; Nurotron Biotechnology Co Ltd; CARMAT SA; Precision Neuroscience; Pins Medical; Lepu Medical Technology Co Ltd; LifeTech Scientific
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Active Implantable Medical Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Active Implantable Medical Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Active Implantable Medical Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Active Implantable Medical Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Integration Of Smart And Connected Implantable Devices
    • 4.2.2 Rising Adoption Of Miniaturized Electronic Components
    • 4.2.3 Growing Use Of Data-Driven Therapeutic Monitoring
    • 4.2.4 Expansion Of Long-Term Implantable Therapies
    • 4.2.5 Enhanced Focus On Device Longevity And Reliability

5. Active Implantable Medical Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Specialty Clinics
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Cardiac Care Centers
  • 5.5 Neurology Clinics

6. Active Implantable Medical Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Active Implantable Medical Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Active Implantable Medical Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Active Implantable Medical Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Active Implantable Medical Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Active Implantable Medical Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Active Implantable Medical Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Active Implantable Medical Devices Market Segmentation

  • 9.1. Global Active Implantable Medical Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiac Pacemakers, Implantable Cardioverter Defibrillators (ICD), Nerve Stimulators, Cochlear Implants, Ventricular Assist Devices, Other Products
  • 9.2. Global Active Implantable Medical Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiovascular, Neurological, Hearing Impairment, Other Applications
  • 9.3. Global Active Implantable Medical Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Specialty Clinics, Ambulatory Surgical Centers
  • 9.4. Global Active Implantable Medical Devices Market, Sub-Segmentation Of Cardiac Pacemakers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single Chamber Pacemakers, Dual Chamber Pacemakers, Biventricular Pacemakers
  • 9.5. Global Active Implantable Medical Devices Market, Sub-Segmentation Of Implantable Cardioverter Defibrillators (ICD), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transvenous ICDs, Subcutaneous ICDs
  • 9.6. Global Active Implantable Medical Devices Market, Sub-Segmentation Of Nerve Stimulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Spinal Cord Stimulators, Peripheral Nerve Stimulators, Deep Brain Stimulators
  • 9.7. Global Active Implantable Medical Devices Market, Sub-Segmentation Of Cochlear Implants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Electrode Cochlear Implants, Multichannel Cochlear Implants
  • 9.8. Global Active Implantable Medical Devices Market, Sub-Segmentation Of Ventricular Assist Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (BiVAD)
  • 9.9. Global Active Implantable Medical Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Neurostimulators for Pain Management, Implantable Drug Delivery Systems, Implantable Blood Pressure Monitors

10. Active Implantable Medical Devices Market Regional And Country Analysis

  • 10.1. Global Active Implantable Medical Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Active Implantable Medical Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Active Implantable Medical Devices Market

  • 11.1. Asia-Pacific Active Implantable Medical Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Active Implantable Medical Devices Market

  • 12.1. China Active Implantable Medical Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Active Implantable Medical Devices Market

  • 13.1. India Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Active Implantable Medical Devices Market

  • 14.1. Japan Active Implantable Medical Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Active Implantable Medical Devices Market

  • 15.1. Australia Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Active Implantable Medical Devices Market

  • 16.1. Indonesia Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Active Implantable Medical Devices Market

  • 17.1. South Korea Active Implantable Medical Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Active Implantable Medical Devices Market

  • 18.1. Taiwan Active Implantable Medical Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Active Implantable Medical Devices Market

  • 19.1. South East Asia Active Implantable Medical Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Active Implantable Medical Devices Market

  • 20.1. Western Europe Active Implantable Medical Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Active Implantable Medical Devices Market

  • 21.1. UK Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Active Implantable Medical Devices Market

  • 22.1. Germany Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Active Implantable Medical Devices Market

  • 23.1. France Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Active Implantable Medical Devices Market

  • 24.1. Italy Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Active Implantable Medical Devices Market

  • 25.1. Spain Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Active Implantable Medical Devices Market

  • 26.1. Eastern Europe Active Implantable Medical Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Active Implantable Medical Devices Market

  • 27.1. Russia Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Active Implantable Medical Devices Market

  • 28.1. North America Active Implantable Medical Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Active Implantable Medical Devices Market

  • 29.1. USA Active Implantable Medical Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Active Implantable Medical Devices Market

  • 30.1. Canada Active Implantable Medical Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Active Implantable Medical Devices Market

  • 31.1. South America Active Implantable Medical Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Active Implantable Medical Devices Market

  • 32.1. Brazil Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Active Implantable Medical Devices Market

  • 33.1. Middle East Active Implantable Medical Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Active Implantable Medical Devices Market

  • 34.1. Africa Active Implantable Medical Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Active Implantable Medical Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Active Implantable Medical Devices Market Regulatory and Investment Landscape

36. Active Implantable Medical Devices Market Competitive Landscape And Company Profiles

  • 36.1. Active Implantable Medical Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Active Implantable Medical Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Active Implantable Medical Devices Market Company Profiles
    • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. BIOTRONIK SE & Co KG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis

37. Active Implantable Medical Devices Market Other Major And Innovative Companies

  • Cochlear Limited, MED-EL Medical Electronics, Sonova Holding AG, NeuroPace Inc, NEVRO Corp, Axonics Inc, Aleva Neurotherapeutics SA, MicroTransponder Inc, Shree Pacetronix, Berlin Heart GmbH, Jarvik Heart Inc, Blackrock Neurotech, Nurotron Biotechnology Co Ltd, CARMAT SA, Precision Neuroscience

38. Global Active Implantable Medical Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Active Implantable Medical Devices Market

40. Active Implantable Medical Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Active Implantable Medical Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Active Implantable Medical Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Active Implantable Medical Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer